Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Esmir Gunic
Discovery and Characterization of Verinurad, a Potent and Specific Inhibitor of URAT1 for the Treatment of Hyperuricemia and Gout
Scientific Reports
Multidisciplinary
Related publications
Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout
Core Evidence
Medicine
Reviews
References
Pharmacology
Discovery of URAT1 SNPs and Association Between Serum Uric Acid Levels and URAT1
BMJ Open
Medicine
Autoinflammation in the Pathogenesis of Gout and Hyperuricemia
Clinical pharmacology and therapy
Diagnosis and Treatment for Hyperuricemia and Gout: A Systematic Review of Clinical Practice Guidelines and Consensus Statements
BMJ Open
Medicine
Urate Transporters: Transforming the Face of Hyperuricemia and Gout
Journal of Rheumatology
Rheumatology
Allergy
Immunology
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-TRK Inhibitor (PF-06273340) for the Treatment of Pain
Intermittent Control of Hyperuricemia in the Treatment of Gout: 186
Pediatric Research
Child Health
Pediatrics
Perinatology
Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
THU0435 Pharmacodynamics, Pharmacokinetics, and Safety of Verinurad (RDEA3170) in Combination With Febuxostat Versus Febuxostat Alone and Verinurad Alone in Japanese Adults With Gout or Asymptomatic Hyperuricemia: A Phase 2A, Open-Label Study
